You just read:

Asterias Biotherapeutics to Present New 9-Month Efficacy Data from AST-OPC1 SCiStar Study at the International Society for Stem Cell Research (ISSCR) 2017 Annual Meeting

News provided by

Asterias Biotherapeutics, Inc.

Jun 08, 2017, 07:00 ET